Results 311 to 320 of about 162,186 (348)

Acinetobacter baumannii and Acinetobacter spp.

2017
Acinetobacter baumannii is a bacterial pathogen increasingly identified in the clinical microbiology laboratory as a cause of infection in humans. Upon microscopic examination, A. baumannii appears as a Gram-negative coccobacillus, and it produces clear colonies when grown on MacConkey agar, indicating its inability to ferment lactose.
Federico Perez, Robert A. Bonomo
openaire   +1 more source

Phage therapy for Acinetobacter baumannii infection

2023
Acinetobacter is a gram-negative nosocomial pathogenic bacteria. The contributing factor for the pathogenicity of Acinetobacter is severe due to its property of antibacterial drug resistance. Often antibiotic treatment is used to treat bacterial infection, however due to the resistance of a broad range of antibiotics by Acinetobacter the treatment ...
Ramneet, Kaur, Dibita, Mandal, Ajay, Kumar   +2 more
openaire   +2 more sources

Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii

Nature Chemical Biology, 2023
Gary Liu, Denise B. Catacutan, Khushi Rathod, Kyle Swanson, Wengong Jin, Jody C. Mohammed, Anush Chiappino-Pepe, Saad Syed, Meghan Fragis, K. Rachwalski, Jakob Magolan, M. Surette, B. Coombes, T. Jaakkola, R. Barzilay, James J. Collins, Jonathan M. Stokes   +16 more
semanticscholar   +1 more source

[Acinetobacter baumannii bacteremia].

Revista medica del Instituto Mexicano del Seguro Social, 2011
Acinetobacter baumannii has emerged as an important nosocomial pathogen. It is difficult to control and treat. The most seriously ill patients and those previously infected are more likely than others to be infected or colonized by A. baumannii. The epidemiology of A.
Guadalupe, Aguirre-Avalos, Julio César, Mijangos-Méndez, Gerardo, Amaya-Tapia   +2 more
openaire   +1 more source

Genetic Manipulation of Acinetobacter baumannii

Current Protocols in Microbiology, 2014
Abstract Acinetobacter baumannii is a Gram‐negative nosocomial pathogen of clinical importance. A lack of genetic tools has hindered the research of this organism in the past; however, recently, various methods have been designed, modified, and optimized to facilitate the genetic manipulation of A. baumannii.
Anna C, Jacobs, Mitchell G, Thompson, Michael, Gebhardt, Brendan W, Corey, Suleyman, Yildirim, Howard A, Shuman, Daniel V, Zurawski   +6 more
openaire   +2 more sources

Acinetobacter baumannii pseudomeningitis

Heart & Lung, 2002
William M, Gusten, Eric A, Hansen, Burke A, Cunha   +2 more
openaire   +2 more sources

Optimizing Therapy for Acinetobacter baumannii

Seminars in Respiratory and Critical Care Medicine, 2007
Acinetobacter baumannii is a highly resilient, gram-negative coccobacillus that thrives within the unique and complex ecological setting of an intensive care unit. This evolving pathogen has now surpassed human capacity to create new antimicrobials, and has led physicians into a concerning era for hospital-acquired infections.
openaire   +2 more sources

[Multidrug-Resistant Acinetobacter baumannii].

Rinsho byori. The Japanese journal of clinical pathology, 2019
Teikyo University Hospital reported an outbreak of multidrug-resistant Acinetobacter baumannii (MDRAB) to the local public health department in 2010. The number of inpatients with MDRAB including asympto- matic carriers was 58 between August 2009 and September 2010.
Miwa, Asahara, Naohisa, Matsunaga, Taiji, Furukawa   +2 more
openaire   +1 more source

Biological nitrogen and phosphorus removal by a phosphorus-accumulating bacteria Acinetobacter sp. strain C-13 with the ability of heterotrophic nitrification–aerobic denitrification

Bioresource Technology, 2021
Weizheng Zhou, Shunni Zhu, Chao Xu
exaly  

Acinetobacter baumannii infections in children

The Lancet Infectious Diseases, 2010
Fernando Maria, de Benedictis, Patrizia, Osimani, Carmelo, Gabriele   +2 more
openaire   +2 more sources